RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma

Journal: Science Advances

Published: 2020-07-01

DOI: 10.1126/sciadv.aba2113

Affiliations: 21

Authors: 18

Go to article
Institutions Share
Department of Developmental Neurobiology, St. Jude, United States of America (USA) 0.11
Huashan Hospital, Fudan University, China 0.11
Shanghai Key Laboratory of Medical Epigenetics, Fudan University, China 0.11
MST MInternational Co-laboratory of Medical Epigenetics and Metabolism, Fudan University, China 0.09
Institutes of Biomedical Sciences (IBS), Fudan University, China 0.09
Shanghai Pudong Hospital, Fudan University, China 0.07
State Key Laboratory of Medical Neurobiology, Fudan University, China 0.06
MOE Frontier Center for Brain Science, Fudan University, China 0.06
Division of Neonatology (Newborn Medicine), BCH, United States of America (USA) 0.06
Harvard Department of Cell Biology, United States of America (USA) 0.06
Brigham and Women's Hospital (BWH), United States of America (USA) 0.06
ICR Division of Molecular Pathology, United Kingdom (UK) 0.06
Human Phenome Institute, Fudan University, China 0.02
School of Life Sciences, Fudan University, China 0.02
State Key Laboratory of Genetic Engineering, Fudan University, China 0.02
Fudan University Shanghai Cancer Center (FUSCC), China 0.02
MOE Key Laboratory of Carcinogenesis and Cancer Invasion, China 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER